Literature DB >> 22488485

Lipids: Monoclonal antibody therapy lowers LDL-cholesterol levels.

Ellen F Carney.   

Abstract

Entities:  

Year:  2012        PMID： 22488485     DOI： 10.1038/nrcardio.2012.55

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.

Authors:  Evan A Stein; Scott Mellis; George D Yancopoulos; Neil Stahl; Douglas Logan; William B Smith; Eleanor Lisbon; Maria Gutierrez; Cheryle Webb; Richard Wu; Yunling Du; Therese Kranz; Evelyn Gasparino; Gary D Swergold
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

2.  Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy.

Authors:  James M McKenney; Michael J Koren; Dean J Kereiakes; Corinne Hanotin; Anne-Catherine Ferrand; Evan A Stein
Journal:  J Am Coll Cardiol       Date:  2012-03-28       Impact factor: 24.094
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.